Berlin/Frankfurt—Global law firm Dentons has advised numerous banks in their capacity as promissory note creditors of Biotronik Group on obtaining repayment of their note loans.

The full repayment was completed on July 30, 2025, following the successful refinancing of Biotronik.

A Dentons team led by Andreas Ziegenhagen has been providing comprehensive advice to Biotronik Group's promissory note creditors since 2023 with regard to the refinancing and related agreements. The team advised the group of creditors and provided intensive support throughout the restructuring period as promissory note representative.

Biotronik is a leading global medical technology company based in Berlin and a pioneer in cardiovascular, endovascular, and neuromodulatory solutions. The company develops and sells products and services that aim to improve the lives of people with cardiovascular disease and chronic pain. Biotronik is represented in over 100 countries in the Americas, EMEA, and Asia-Pacific regions. 

Advisors to Biotronik’s promissory note creditors:

Dentons (Berlin/Düsseldorf/Frankfurt): Andreas Ziegenhagen (Lead Partner, Restructuring, Berlin), Oliver Dreher (Partner, Banking and Finance, Frankfurt), Philippa Münnich-Winter, Detlef Spranger (both Counsel, both Berlin), Tobias Schröter (Senior Associate, Düsseldorf), Yasmin Mohammadi (Senior Associate), Mariam Lomtatidze (Associate, both Berlin, all Restructuring), Sven Henneke (Associate, Banking and Finance, Frankfurt), Luis Anton Michalzik (both Legal Project Manager, Banking and Finance, Frankfurt)

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com